Search

everythinglearnresearchcommunity

for

Search:↓

Stigmatization and quality of life in people with alopecia are influenced by gender and sociodemographics, suggesting a need for better support.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Alopecia areata causes patchy hair loss due to the immune system attacking hair follicles.

Alopecia areata patients don't have increased atherosclerosis risk, but may have higher cardiovascular risk due to smoking, blood sugar, and blood pressure.

Both cryotherapy and FCO2 laser are effective and safe for treating patchy alopecia areata.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Higher levels of β-carotene and vitamin E may help prevent certain types of hair loss.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Lasers and light therapies are effective in promoting hair regrowth for different types of hair loss.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Children with alopecia areata in Singapore generally have a good quality of life.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

The document concludes that more research is needed to confirm if COVID-19 vaccines cause a type of hair loss called alopecia areata.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

New hair loss treatments could be improved by using combined biological markers.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

PRP is an effective and safe treatment for alopecia areata.

A child has a rare hair and skin disorder due to specific gene variants, suggesting broader genetic testing is needed.

A new model accurately predicts water intake in hair sheep using dry matter intake.

A hair implant clinic in Bogotá is feasible and can offer affordable treatments for medium-income individuals.

A 5% minoxidil spray could effectively treat male baldness with fewer side effects and better patient comfort.